Kim SG - Search Results

1

Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

Kim MH, Kim GM, Ahn JM, Ryu WJ, Kim SG, Kim JH, Kim TY, Han HJ, Kim JY, Park HS, Park S, Park BW, Kim SI, Jeong J, Lee J, Paik S, Kim S, Jung KH, Cho EH, Sohn J. Kim MH, et al. Among authors: kim jy, kim sg, kim ty, kim gm, kim si, kim s, kim jh. J Natl Cancer Inst. 2023 Sep 7;115(9):1036-1049. doi: 10.1093/jnci/djad080. J Natl Cancer Inst. 2023. PMID: 37166557 Free PMC article.

2

Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP.

Ji JH, Bae SJ, Kim SG, Kim MH, Kim GM, Sohn J, Jeong J, Kim JH, Ahn SG. Ji JH, et al. Among authors: kim sg, kim gm, kim mh, kim jh. Cancer Med. 2023 Jan;12(2):1409-1417. doi: 10.1002/cam4.5022. Epub 2022 Jul 15. Cancer Med. 2023. PMID: 35837812 Free PMC article.

3

On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.

Kim CG, Kim MH, Kim JH, Kim SG, Kim GM, Kim TY, Ryu WJ, Kim JY, Park HS, Park S, Cho YU, Park BW, Kim SI, Jeong J, Sohn J. Kim CG, et al. Among authors: kim jy, kim sg, kim ty, kim gm, kim si, kim mh, kim jh. Breast Cancer Res. 2023 Jan 12;25(1):4. doi: 10.1186/s13058-022-01601-4. Breast Cancer Res. 2023. PMID: 36635767 Free PMC article.

4

Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer.

Kim SG, Kim MH, Park S, Kim GM, Kim JH, Kim JY, Park HS, Park S, Park BW, Kim SI, Ji JH, Jeong J, Shin K, Lee J, Kim HD, Jung KH, Sohn J. Kim SG, et al. Among authors: kim jy, kim gm, kim si, kim mh, kim hd, kim jh. Cancer Res Treat. 2023 Oct;55(4):1198-1209. doi: 10.4143/crt.2022.1543. Epub 2023 Apr 11. Cancer Res Treat. 2023. PMID: 37054718 Free PMC article.

5

Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.

Katuwal NB, Kang MS, Ghosh M, Hong SD, Jeong YG, Park SM, Kim SG, Sohn J, Kim TH, Moon YW. Katuwal NB, et al. Among authors: kim sg, kim th. J Exp Clin Cancer Res. 2023 Nov 28;42(1):325. doi: 10.1186/s13046-023-02903-x. J Exp Clin Cancer Res. 2023. PMID: 38017459 Free PMC article.

6

Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis.

Park S, Nam CM, Kim SG, Mun JE, Rha SY, Chung HC. Park S, et al. Among authors: kim sg. Eur J Cancer. 2021 Feb;144:49-60. doi: 10.1016/j.ejca.2020.10.030. Epub 2020 Dec 15. Eur J Cancer. 2021. PMID: 33338727

7

Preclinical Platform Using a Triple-negative Breast Cancer Syngeneic Murine Model to Evaluate Immune Checkpoint Inhibitors.

Katuwal NB, Park N, Pandey K, Kang MS, Hong SD, Ghosh M, Kim SG, Cho YB, Hur J, Kim SK, Moon YW. Katuwal NB, et al. Among authors: kim sg, kim sk. Anticancer Res. 2023 Jan;43(1):85-95. doi: 10.21873/anticanres.16137. Anticancer Res. 2023. PMID: 36585194

8

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer.

Ghosh M, Kang MS, Katuwal NB, Hong SD, Jeong YG, Park SM, Kim SG, Moon YW. Ghosh M, et al. Among authors: kim sg. Int J Mol Sci. 2023 Dec 3;24(23):17086. doi: 10.3390/ijms242317086. Int J Mol Sci. 2023. PMID: 38069409 Free PMC article.

9

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma.

Sang YB, Yang H, Lee WS, Lee SJ, Kim SG, Cheon J, Kang B, Kim CW, Chon HJ, Kim C. Sang YB, et al. Among authors: kim sg, kim cw, kim c. Cancers (Basel). 2022 Dec 3;14(23):5985. doi: 10.3390/cancers14235985. Cancers (Basel). 2022. PMID: 36497467 Free PMC article.

10

Combined PI3K Inhibitor and Eribulin Enhances Anti-Tumor Activity in Preclinical Models of Paclitaxel-Resistant, PIK3CA-Mutated Endometrial Cancer.

Jeong YG, Katuwal NB, Kang MS, Ghosh M, Hong SD, Park SM, Kim SG, Kim TH, Moon YW. Jeong YG, et al. Among authors: kim sg, kim th. Cancers (Basel). 2023 Oct 8;15(19):4887. doi: 10.3390/cancers15194887. Cancers (Basel). 2023. PMID: 37835582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,659 results

Search Page